Results of the September 2019 CCS/CIHR Cancer Survivorship Team Grants, in partnership with ACF competition

We are pleased to announce the recipients of the CCS/CIHR Cancer Survivorship Team Grants, in partnership with the Alberta Cancer Foundation (ACF). The goal of the program is to improve the health outcomes for cancer survivors of all ages from the time of their cancer diagnosis until the time of their death or entry into end-of-life care. Collectively, successful teams will be expected to generate relevant new knowledge and to develop and evaluate practical strategies and interventions, in real world settings, that will prevent or diminish the adverse sequelae of a cancer diagnosis and have a positive impact on subsequent health outcomes for cancer survivors.

Below is a listing of the funded CCS/CIHR Cancer Survivorship Team Grants, in partnership with ACF.

6 Team Grants have been approved - 22% of all full proposals received. 33 Abstracts were submitted to the competition, and following a relevance review 31 of these were invited to submit full applications, and 27 were received. Grants are valued at up to $2.5M over a 5-year term. The initial budget for this competition was $10 million and 4 grants, but with the support of the Alberta Cancer Foundation and McMaster University, we were able to award 6 grants. These 6 new grants represent a significant investment of nearly $13.4 million.

Abstracts of awarded grants

Please note: 

  • Amounts listed below represent the total dollars awarded by grant year and may include funds for salaries, supplies, and/or equipment.
  • The start date for these grants is December 1, 2019.
  • Only the Principal Investigator is named in this listing. Co-Principal Investigators, Co-Applicants and/or Additional Authors may also be associated with these grants.

Applicant
Institution
Title
Award
Cafazzo, Joseph
The Toronto Hospital (General Division) UHN
Virtualizing survivorship: implementing a more timely and comprehensive model of follow up care

2019/2020 :  $492,520
2020/2021 :  $477,985
2021/2022 :  $475,445
2022/2023 :  $479,245
2023/2024 :  $483,950
Culos Reed, S. Nicole
University of Calgary
Dissemination, implementation, and effectiveness of the exercise oncology survivorship partnership model: reaching rural cancer survivors to enhance quality of life
(in partnership with the Alberta Cancer Foundation)

2019/2020 :  $500,000
2020/2021 :  $500,000
2021/2022 :  $500,000
2022/2023 :  $500,000
2023/2024 :  $500,000
Jones, Jennifer
Princess Margaret Cancer Centre UHN
Canadian cancer rehabilitation (CanRehab) team: improving the systematic identification, management, and treatment of the adverse effects of cancer

2019/2020 :  $499,997
2020/2021 :  $499,937
2021/2022 :  $431,378
2022/2023 :  $445,735
2023/2024 :  $500,000
Leong, Darryl
McMaster University
Addressing cardiovascular co morbidities in patients with cancer (C3)
(with support from McMaster University)

2019/2020 :  $499,885
2020/2021 :  $498,901
2021/2022 :  $499,116
2022/2023 :  $493,041
2023/2024 :  $393,378
Mabbott, Donald
The Hospital for Sick Children
Phase III randomized double blind placebo controlled trial of metformin for cognitive recovery and white matter growth in paediatric medulloblastoma patients

2019/2020 :  $497,000
2020/2021 :  $447,078
2021/2022 :  $482,548
2022/2023 :  $474,548
2023/2024 :  $444,748
Quan, May Lynn
University of Calgary
Preparing to survive: Improving outcomes for young women with breast cancer
(in partnership with the Alberta Cancer Foundation)

2019/2020 :  $406,293
2020/2021 :  $134,590
2021/2022 :  $80,962
2022/2023 :  $79,012
2023/2024 :  $116,912

Last modified on: June 2, 2020